CN Stock MarketDetailed Quotes

688621 Beijing Sun-Novo Pharmaceutical Research

Watchlist
  • 35.90
  • -0.57-1.56%
Market Closed Jan 3 15:00 CST
4.02BMarket Cap18.16P/E (TTM)

Beijing Sun-Novo Pharmaceutical Research Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
32.47%916.68M
22.08%562.86M
8.53%252.26M
37.76%932.12M
39.73%692M
42.16%461.05M
57.09%232.43M
37.06%676.61M
45.19%495.24M
44.71%324.31M
Operating revenue
32.47%916.68M
22.08%562.86M
8.53%252.26M
37.76%932.12M
39.73%692M
42.16%461.05M
57.09%232.43M
37.06%676.61M
45.19%495.24M
44.71%324.31M
Total operating cost
38.04%670.05M
22.52%388.53M
0.68%172.41M
35.63%686.94M
37.45%485.4M
40.68%317.12M
58.75%171.24M
38.22%506.49M
48.12%353.14M
48.87%225.41M
Operating cost
44.38%438.66M
24.75%247.73M
-13.50%101.97M
34.08%403.77M
42.38%303.83M
47.08%198.59M
83.54%117.88M
30.95%301.15M
43.55%213.39M
35.85%135.02M
Operating tax surcharges
42.83%1.23M
36.27%617.62K
189.70%338.54K
11.84%1.25M
2.79%863.09K
-18.84%453.25K
-65.75%116.86K
122.41%1.12M
107.65%839.7K
229.09%558.44K
Operating expense
56.71%30.4M
47.37%17.45M
29.22%8.51M
116.01%43.79M
34.95%19.4M
19.81%11.84M
25.20%6.59M
19.04%20.27M
25.18%14.38M
43.34%9.88M
Administration expense
-2.82%72.7M
-3.60%48.92M
-7.21%24.66M
20.88%109.45M
14.60%74.81M
20.95%50.75M
32.67%26.58M
31.99%90.54M
59.28%65.28M
73.00%41.96M
Financial expense
124.45%7.55M
121.88%4.71M
160.75%1.96M
33.92%5M
31.46%3.36M
14.24%2.12M
-38.26%751.62K
34.75%3.73M
110.90%2.56M
99.76%1.86M
-Interest expense (Financial expense)
47.01%12.13M
59.87%8.35M
76.29%4.13M
25.55%12.18M
14.89%8.25M
12.82%5.22M
61.95%2.34M
172.10%9.7M
316.64%7.18M
337.39%4.63M
-Interest Income (Financial expense)
6.09%-4.63M
-17.14%-3.67M
-35.76%-2.18M
-17.69%-7.24M
-5.91%-4.93M
-12.06%-3.13M
-61.77%-1.61M
-630.90%-6.15M
-719.59%-4.66M
-1,670.04%-2.79M
Research and development
43.76%119.51M
29.48%69.09M
80.85%34.97M
37.91%123.68M
46.61%83.13M
47.71%53.36M
15.14%19.33M
88.51%89.69M
58.92%56.7M
82.69%36.13M
Credit Impairment Loss
-18.17%-34.19M
-33.01%-26.91M
-28.12%-13.08M
-209.52%-60.18M
-102.62%-28.94M
-143.97%-20.23M
-142.07%-10.21M
-74.55%-19.44M
-102.05%-14.28M
-37.46%-8.29M
Other net revenue
Invest income
-33.83%317.92K
-27.48%232.92K
-0.04%159.25K
-50.80%1.29M
-81.05%480.43K
-87.13%321.18K
-90.44%159.31K
55.93%2.62M
346.87%2.53M
624.75%2.5M
Asset deal income
----
----
----
----
----
----
----
-2,554.54%-36.82K
257.16%5.61K
----
Other revenue
75.86%9.35M
91.35%8.69M
462.24%7.5M
-50.89%7.87M
-34.37%5.32M
-3.57%4.54M
32.96%1.33M
230.97%16.02M
122.76%8.1M
34.18%4.71M
Operating profit
21.06%222.11M
21.62%156.34M
41.85%74.43M
14.70%194.16M
32.51%183.47M
31.44%128.56M
36.14%52.47M
38.08%169.27M
38.71%138.46M
38.70%97.81M
Add:Non operating Income
-76.74%2.01K
-61.07%2K
75.70%2K
-89.49%10.08K
4.46%8.63K
-17.87%5.14K
-99.14%1.14K
88.80%95.87K
-25.21%8.26K
-32.30%6.26K
Less:Non operating expense
215.93%1.58M
2,173.89%1.53M
134.19%122.8K
233.66%774.6K
167.15%499.9K
1,722.63%67.21K
6,976.76%52.44K
-57.06%232.15K
-22.47%187.12K
-98.46%3.69K
Total profit
20.52%220.53M
20.49%154.82M
41.76%74.31M
14.34%193.4M
32.32%182.98M
31.37%128.49M
35.55%52.42M
38.52%169.14M
38.85%138.28M
39.16%97.81M
Less:Income tax cost
61.95%16.73M
46.65%13.47M
23.13%5.57M
0.65%10.5M
30.36%10.33M
-14.60%9.19M
17.91%4.52M
-21.60%10.43M
-37.31%7.92M
7.81%10.76M
Net profit
18.04%203.8M
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
37.49%47.9M
45.88%158.7M
49.92%130.36M
44.35%87.06M
Net profit from continuing operation
18.04%203.8M
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
37.49%47.9M
45.88%158.7M
49.92%130.36M
44.35%87.06M
Less:Minority Profit
-347.27%-3.89M
-649.40%-7.22M
-10,351.48%-4.01M
-183.48%-1.86M
8.28%1.57M
503.24%1.31M
-102.67%-38.38K
-28.71%2.23M
-20.09%1.45M
-124.22%-326.06K
Net profit of parent company owners
21.40%207.69M
25.91%148.57M
51.77%72.75M
18.08%184.76M
32.72%171.08M
35.03%117.99M
43.52%47.94M
48.09%156.47M
51.42%128.9M
48.19%87.38M
Earning per share
Basic earning per share
20.92%1.85
26.67%1.33
51.16%0.65
17.86%1.65
33.04%1.53
34.62%1.05
2.38%0.43
-7.28%1.4
-19.01%1.15
-20.41%0.78
Diluted earning per share
20.92%1.85
26.67%1.33
51.16%0.65
17.86%1.65
33.04%1.53
34.62%1.05
2.38%0.43
-7.28%1.4
-19.01%1.15
-20.41%0.78
Other composite income
Total composite income
18.04%203.8M
18.47%141.35M
43.52%68.74M
15.24%182.9M
32.44%172.65M
37.05%119.31M
37.49%47.9M
45.88%158.7M
49.92%130.36M
44.35%87.06M
Total composite income of parent company owners
21.40%207.69M
25.91%148.57M
51.77%72.75M
18.08%184.76M
32.72%171.08M
35.03%117.99M
43.52%47.94M
48.09%156.47M
51.42%128.9M
48.19%87.38M
Total composite income of minority owners
-347.27%-3.89M
-649.40%-7.22M
-10,351.48%-4.01M
-183.48%-1.86M
8.28%1.57M
503.24%1.31M
-102.67%-38.38K
-28.71%2.23M
-20.09%1.45M
-124.22%-326.06K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024 (Q6)Jun 30, 2024 (Q3)Mar 31, 2024 (FY)Dec 31, 2023 (Q9)Sep 30, 2023 (Q6)Jun 30, 2023 (Q3)Mar 31, 2023 (FY)Dec 31, 2022 (Q9)Sep 30, 2022 (Q6)Jun 30, 2022
Total operating revenue 32.47%916.68M 22.08%562.86M 8.53%252.26M 37.76%932.12M 39.73%692M 42.16%461.05M 57.09%232.43M 37.06%676.61M 45.19%495.24M 44.71%324.31M
Operating revenue 32.47%916.68M 22.08%562.86M 8.53%252.26M 37.76%932.12M 39.73%692M 42.16%461.05M 57.09%232.43M 37.06%676.61M 45.19%495.24M 44.71%324.31M
Total operating cost 38.04%670.05M 22.52%388.53M 0.68%172.41M 35.63%686.94M 37.45%485.4M 40.68%317.12M 58.75%171.24M 38.22%506.49M 48.12%353.14M 48.87%225.41M
Operating cost 44.38%438.66M 24.75%247.73M -13.50%101.97M 34.08%403.77M 42.38%303.83M 47.08%198.59M 83.54%117.88M 30.95%301.15M 43.55%213.39M 35.85%135.02M
Operating tax surcharges 42.83%1.23M 36.27%617.62K 189.70%338.54K 11.84%1.25M 2.79%863.09K -18.84%453.25K -65.75%116.86K 122.41%1.12M 107.65%839.7K 229.09%558.44K
Operating expense 56.71%30.4M 47.37%17.45M 29.22%8.51M 116.01%43.79M 34.95%19.4M 19.81%11.84M 25.20%6.59M 19.04%20.27M 25.18%14.38M 43.34%9.88M
Administration expense -2.82%72.7M -3.60%48.92M -7.21%24.66M 20.88%109.45M 14.60%74.81M 20.95%50.75M 32.67%26.58M 31.99%90.54M 59.28%65.28M 73.00%41.96M
Financial expense 124.45%7.55M 121.88%4.71M 160.75%1.96M 33.92%5M 31.46%3.36M 14.24%2.12M -38.26%751.62K 34.75%3.73M 110.90%2.56M 99.76%1.86M
-Interest expense (Financial expense) 47.01%12.13M 59.87%8.35M 76.29%4.13M 25.55%12.18M 14.89%8.25M 12.82%5.22M 61.95%2.34M 172.10%9.7M 316.64%7.18M 337.39%4.63M
-Interest Income (Financial expense) 6.09%-4.63M -17.14%-3.67M -35.76%-2.18M -17.69%-7.24M -5.91%-4.93M -12.06%-3.13M -61.77%-1.61M -630.90%-6.15M -719.59%-4.66M -1,670.04%-2.79M
Research and development 43.76%119.51M 29.48%69.09M 80.85%34.97M 37.91%123.68M 46.61%83.13M 47.71%53.36M 15.14%19.33M 88.51%89.69M 58.92%56.7M 82.69%36.13M
Credit Impairment Loss -18.17%-34.19M -33.01%-26.91M -28.12%-13.08M -209.52%-60.18M -102.62%-28.94M -143.97%-20.23M -142.07%-10.21M -74.55%-19.44M -102.05%-14.28M -37.46%-8.29M
Other net revenue
Invest income -33.83%317.92K -27.48%232.92K -0.04%159.25K -50.80%1.29M -81.05%480.43K -87.13%321.18K -90.44%159.31K 55.93%2.62M 346.87%2.53M 624.75%2.5M
Asset deal income ---- ---- ---- ---- ---- ---- ---- -2,554.54%-36.82K 257.16%5.61K ----
Other revenue 75.86%9.35M 91.35%8.69M 462.24%7.5M -50.89%7.87M -34.37%5.32M -3.57%4.54M 32.96%1.33M 230.97%16.02M 122.76%8.1M 34.18%4.71M
Operating profit 21.06%222.11M 21.62%156.34M 41.85%74.43M 14.70%194.16M 32.51%183.47M 31.44%128.56M 36.14%52.47M 38.08%169.27M 38.71%138.46M 38.70%97.81M
Add:Non operating Income -76.74%2.01K -61.07%2K 75.70%2K -89.49%10.08K 4.46%8.63K -17.87%5.14K -99.14%1.14K 88.80%95.87K -25.21%8.26K -32.30%6.26K
Less:Non operating expense 215.93%1.58M 2,173.89%1.53M 134.19%122.8K 233.66%774.6K 167.15%499.9K 1,722.63%67.21K 6,976.76%52.44K -57.06%232.15K -22.47%187.12K -98.46%3.69K
Total profit 20.52%220.53M 20.49%154.82M 41.76%74.31M 14.34%193.4M 32.32%182.98M 31.37%128.49M 35.55%52.42M 38.52%169.14M 38.85%138.28M 39.16%97.81M
Less:Income tax cost 61.95%16.73M 46.65%13.47M 23.13%5.57M 0.65%10.5M 30.36%10.33M -14.60%9.19M 17.91%4.52M -21.60%10.43M -37.31%7.92M 7.81%10.76M
Net profit 18.04%203.8M 18.47%141.35M 43.52%68.74M 15.24%182.9M 32.44%172.65M 37.05%119.31M 37.49%47.9M 45.88%158.7M 49.92%130.36M 44.35%87.06M
Net profit from continuing operation 18.04%203.8M 18.47%141.35M 43.52%68.74M 15.24%182.9M 32.44%172.65M 37.05%119.31M 37.49%47.9M 45.88%158.7M 49.92%130.36M 44.35%87.06M
Less:Minority Profit -347.27%-3.89M -649.40%-7.22M -10,351.48%-4.01M -183.48%-1.86M 8.28%1.57M 503.24%1.31M -102.67%-38.38K -28.71%2.23M -20.09%1.45M -124.22%-326.06K
Net profit of parent company owners 21.40%207.69M 25.91%148.57M 51.77%72.75M 18.08%184.76M 32.72%171.08M 35.03%117.99M 43.52%47.94M 48.09%156.47M 51.42%128.9M 48.19%87.38M
Earning per share
Basic earning per share 20.92%1.85 26.67%1.33 51.16%0.65 17.86%1.65 33.04%1.53 34.62%1.05 2.38%0.43 -7.28%1.4 -19.01%1.15 -20.41%0.78
Diluted earning per share 20.92%1.85 26.67%1.33 51.16%0.65 17.86%1.65 33.04%1.53 34.62%1.05 2.38%0.43 -7.28%1.4 -19.01%1.15 -20.41%0.78
Other composite income
Total composite income 18.04%203.8M 18.47%141.35M 43.52%68.74M 15.24%182.9M 32.44%172.65M 37.05%119.31M 37.49%47.9M 45.88%158.7M 49.92%130.36M 44.35%87.06M
Total composite income of parent company owners 21.40%207.69M 25.91%148.57M 51.77%72.75M 18.08%184.76M 32.72%171.08M 35.03%117.99M 43.52%47.94M 48.09%156.47M 51.42%128.9M 48.19%87.38M
Total composite income of minority owners -347.27%-3.89M -649.40%-7.22M -10,351.48%-4.01M -183.48%-1.86M 8.28%1.57M 503.24%1.31M -102.67%-38.38K -28.71%2.23M -20.09%1.45M -124.22%-326.06K
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007)
Audit Opinions -- -- -- Unqualified opinion -- -- -- Unqualified opinion -- --
Auditor -- -- -- Dahua Certified Public Accountants (Special General Partnership) -- -- -- Dahua Certified Public Accountants (Special General Partnership) -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Innovative Drugs
Innovative Drugs
Intraday-1.01%
ShangHai Stock Connect
ShangHai Stock Connect
Intraday-1.26%
Transferring Securities of Securities
Transferring Securities of Securities
Intraday-1.58%